Indian Journal of Nuclear Medicine

: 2015  |  Volume : 30  |  Issue : 1  |  Page : 90-

175Yb-TTHMP for bone pain palliation

Sim Sai Tin1, Viroj Wiwanitkit2,  
1 Medical Center, Shantou, China
2 Hainan Medical University, China

Correspondence Address:
Porf. Sim Sai Tin
Medical Center, Shantou

How to cite this article:
Tin SS, Wiwanitkit V. 175Yb-TTHMP for bone pain palliation.Indian J Nucl Med 2015;30:90-90

How to cite this URL:
Tin SS, Wiwanitkit V. 175Yb-TTHMP for bone pain palliation. Indian J Nucl Med [serial online] 2015 [cited 2020 Feb 18 ];30:90-90
Available from:

Full Text


We would like to discuss on the publication on " 175 Yb-TTHMP for bone pain palliation." [1] Safarzadeh proposed " 175 Yb-TTHMP can be a good candidate for bone pain palliation and substitute of other radiopharmaceuticals." [1] The production of 175 Yb is the first consideration. Since preparation of 175 Yb requires specific standard atomic chemistry center, it might be limited prepared and distributed for actual clinical usage. [2] Second, since 175 Yb is rather limited study, its actual effect and adverse effect are still unknown. Dosage that can be problematic has never been clarified, and this is an issue for further studying. [3] Finally, to control of bone pain, not only finding the new palliative agent but also the good holistic care, including psychological support, is needed. [4]


1Safarzadeh L. 175 Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals. Indian J Nucl Med 2014;29:135-9.
2Chakraborty S, Unni PR, Venkatesh M, Pillai MR. Feasibility study for production of 175 Yb: A promising therapeutic radionuclide. Appl Radiat Isot 2002;57:295-301.
3Kaurin DG, Baum JW, Carsten AL, Schaefer CW. Scab incidence on pig skin resulting from hot particle exposures under varying conditions. Health Phys 2001;81:47-56.
4Barton MB, Dawson R, Jacob S, Currow D, Stevens G, Morgan G. Palliative radiotherapy of bone metastases: An evaluation of outcome measures. J Eval Clin Pract 2001;7:47-64.